Holly Fernandez Lynch JD, MBE

faculty photo
Assistant Professor of Medical Ethics and Health Policy at the Hospital of the University of Pennsylvania
Assistant Faculty Director , Online Education Initiatives, Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine
Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania
Affiliated Faculty, Center for Technology, Innovation, and Competition, Penn Carey Law School
Antiracism, Diversity, Equity, & Inclusion (ADEI) Vice Chair, Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine
Department: Medical Ethics and Health Policy

Contact information
Blockley Hall, Room 1426
423 Guardian Drive
Philadelphia, PA 19104
Office: 215-746-7327
BA (Health and Societies)
University of Pennsylvania College of Arts and Sciences, 2003.
MBE (Bioethics)
University of Pennsylvania School of Medicine, 2006.
JD (Law)
University of Pennsylvania Law School, 2006.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Lynch HF: Supreme Court Hearing Abortion Pill Case. Scripps News Live March 2024 Notes: https://video.snapstream.net/Play/7u0n6PNc4F9nZE4X4uFTqk?accessToken=f7f95bj5drm9.

Jacobs E, Earp BD, Appelbaum PS, Bruce L, Cassidy K, Celidwen Y, Cheung K, Clancy SK, Devenot N, Evans J, Lynch HF, Friesen P, Romeu AG, Gehani N, Maloof M, Marcus O, Moen OM, Mertens M, Nayak SM, Noorani T, Patch K, Porsdam-Mann S, Raj G, Rajwani K, Ray K, Smith W, Villiger D, Levy N, Crisp R, Savulescu J, Singh I, Yaden DB: The Hopkins-Oxford Psychedelics Ethics (HOPE) Working Group Consensus Statement. American Journal of Bioethics Online first 2024.

Lynch HF, Lurie P, Cohen IG: Viewpoint: Holding FDA Accountable (peer reviewed). JAMA In press 2024.

Lynch HF, Kesselheim AS: Viewpoint: FDA in the Crosshairs: Science, Politics, and Abortion (invited, peer reviewed). JAMA 331(15): 1269-1270, 2024 Notes: With interview: https://edhub.ama-assn.org/jn-learning/audio-player/18866351.

Lynch HF: "A dilemma in ALS, the first MASH drug, & why gene therapy is hard" STAT The Readout Loud (podcast) 2024 Notes: https://www.statnews.com/2024/03/14/readout-loud-podcast-als-amylyx-mash-gene-therapy-sickle-cell/

Etkin J, Ross J, Lynch HF, Mooghali M, Ramachandran R: Public Comment - FDA-2023-D-2318: Demonstrating Substantial Evidence of Effectiveness with One Adequate and Well-Controlled Clinical Investigation and Confirmatory Evidence. FDA Public Docket December 2023 Notes: https://www.regulations.gov/comment/FDA-2023-D-2318-0018.

Lynch HF, Ramachandran R (with signatories): Expert Letter to Congressional Sponsors re: The Promising Pathway Act Congressional Record December 2023 Notes: https://doctorsforamerica.org/wp-content/uploads/2023/12/Congress-Letter-Promising-Pathway-Act-12.04.23-FINAL.pdf.

Lynch HF, Kearns L, Moch K, Caplan AL: What’s the Worst That Could Happen? A Toothless FDA. Health Affairs Forefront November 2023 Notes: https://www.healthaffairs.org/content/forefront/s-worst-could-happen-toothless-fda.

Lynch HF: "Miracle Drugs, Million Dollar Price Tags" "playing god?" (podcast, hosted by Johns Hopkins Berman Institute of Bioethics) November 2023.

Lynch HF: “Life in the Fast Lane: Navigating Accelerated Drug Approval” MedPage Today, Instagram Live October 2023.

back to top
Last updated: 06/07/2024
The Trustees of the University of Pennsylvania